Retraction: Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability

Min-Wu Chao; Po-Chen Chu; Hsiao-Ching Chuang; Fang-Hsiu Shen; Chih-Chien Chou; En-Chi Hsu; Lauren E. Himmel; Han-Li Huang; Huang-Ju Tu; Samuel K. Kulp; Che-Ming Teng; Ching-Shih Chen

doi:10.18632/oncotarget.27533

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability

PDF | How to cite

Oncotarget. 2020; 11:1096-1096. https://doi.org/10.18632/oncotarget.27533

Metrics: PDF 1303 views | ?

Min-Wu Chao^1,2, Po-Chen Chu^1,3, Hsiao-Ching Chuang¹, Fang-Hsiu Shen³, Chih-Chien Chou¹, En-Chi Hsu¹, Lauren E. Himmel^1,4, Han-Li Huang², Huang-Ju Tu², Samuel K. Kulp¹, Che-Ming Teng², Ching-Shih Chen^1,3

¹ Division of Medicinal Chemistry, College of Pharmacy and Comprehensive Cancer Center, Columbus, Ohio, USA
² Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
³ Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan
⁴ Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA

Published: March 24, 2020

This article has been retracted: The Program for Promotion of Research Integrity (PPRI), Academia Sinica, Taiwan, after twenty months of extensive and thorough investigation, has concluded that this paper should be retracted, because of evidence showing that Dr. Ching-Shih Chen manipulated sixteen (16) images.

The investigation reports can be downloaded from this link (the two PDFs at the bottom of the page): https://ae.daais.sinica.edu.tw/site/datas/detail/2036/30/183/194/0

The Academia Sinica’s news release in English can be found here: https://www.sinica.edu.tw/en/news/6469

The Chinese version of the news release can be found here: https://www.sinica.edu.tw/ch/news/6469

Ohio State University reported that Dr. Ching-Shih Chen had manipulated images in at least 14 papers in different journals. Eight of them required a retraction.

As of today, 11 papers of Dr. Ching-Shih Chen were retracted from different journals.

Original article: Oncotarget. 2016; 7:1796–1807. DOI: https://doi.org/10.18632/oncotarget.6427.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27533

Publication Alerts

Retraction:

Retraction: Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability